OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract 6637: Inhibition of FGFR signaling by lenvatinib activates tumor interferon gamma signaling pathway and potentiates antitumor activity of anti-PD-1 antibody

HTML

Year: 2020
Type: conference-abstract
Source: Cancer Research
DOI: 10.1158/1538-7445.am2020-6637
Authors: Yusuke Adachi, Hiroshi Kamiyama, Kenji Ichikawa, Yoichi Ozawa, Sayo Fukushima, Satoshi Goda, Shogo Yamaguchi, Masahiro Matsuki, Saori Watanabe Miyano, Akira Yokoi, Yu Kato, Yasuhiro Funahashi
Institution: Eisai (Japan)
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: lenvatinib, FGFR signaling, interferon-gamma signaling, anti-PD-1 therapy, anti-PD-1, renal cell carcinoma, axitinib, VEGF inhibition, PD-L1 expression, STAT1 phosphorylation, SOCS1, JAK/STAT signaling, tumor microenvironment, combination immunotherapy, immune checkpoint inhibitors, tyrosine kinase inhibitors, endometrial cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W3083321144
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security